Continuous Glucose Monitors Reveal Hidden Eye Nerve Damage in Type 2 Diabetes
New study shows CGM metrics better predict diabetic nerve damage in the eye than traditional blood sugar tests alone.
20 articles
New study shows CGM metrics better predict diabetic nerve damage in the eye than traditional blood sugar tests alone.
Acromegaly goes undiagnosed for up to a decade. New AI tools and refined hormone assays may finally change that.
Study reveals gap in thyroid monitoring for patients taking levothyroxine who start GLP-1 medications despite weight loss effects.
New research reveals how specific protein expressions in insulinomas determine whether patients experience hypoglycemia only after meals or continuously.
A correction notice updates a recent systematic review and meta-analysis on closed-loop insulin systems in young children with type 1 diabetes.
Study finds exenatide enhances endogenous GLP-1 secretion in type 2 diabetes patients, potentially improving metabolic health.
Somatostatin receptor antagonist enhances protective glucagon response during hypoglycemia without worsening diabetes control.
A third of focal congenital hyperinsulinism cases showed spontaneous glycemic improvement, raising questions about routine surgical intervention.
New sequencing technology identifies genetic diabetes forms in 17% of suspected cases, enabling personalized treatment approaches.
A nationwide cohort study finds GLP-1 receptor agonists do not increase malignancy risk in Cushing's syndrome patients, despite their already elevated cancer burden.
Study reveals how growth hormone both helps and harms glucose metabolism, with major implications for diabetes and aging.
A novel saliva-based marker for dexamethasone absorption may enable at-home Cushing's screening, cutting clinic visits.
A GLP-1 receptor-targeted PET/CT scan located insulin-secreting tumors in nearly three-quarters of patients where conventional imaging had failed.
A Spanish multicenter study finds urinary cortisol thresholds can reliably distinguish two life-threatening forms of Cushing's syndrome.
A biomarker-guided treatment strategy outperforms traditional stepwise therapy, achieving hormonal control in nearly 80% of acromegaly patients.
Even after biochemical remission, Cushing patients with normalized nighttime cortisol show dramatically better mood, energy, and quality of life.
Scientists discover HCY-NBD compound that prevents vascular aging by stabilizing protective GSTM2 protein in diabetic conditions.
A major review updates clinicians on managing acromegaly's wide-ranging complications, from heart disease to cancer risk.
A single sleepless night impairs glucose tolerance the following morning, independent of hormone levels in reproductive-aged women.
Research reveals how glucose signaling through ChREBP protein helps preserve muscle mass in diabetes, offering new therapeutic targets.